Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study.
Bonkovsky
H L
HL
Bonkovsky
M L
ML
Anderson
P B
PB
Rothstein
R I
RI
Erkkinen
J F
JF
D001262:Atenolol / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004932:Esophageal and Gastric Varices / Q000150:complications*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D008103:Liver Cirrhosis / Q000150:complications; D010865:Pilot Projects; D011897:Random Allocation
D001262:Atenolol